Together, these findings suggest that DCI targets both transcriptional and post-translational levels of insulin signaling regulation, counteracting hippocampal insulin resistance and potentially supporting synaptic integrity and neuroprotection in AD. The gene discussed is ECI1; the disease is Alzheimer disease.